Earnings Per Share
EPS (Basic)
Vertex Pharmaceuticals EPS (Basic) increased by 10.4% to $4.68 in Q4 2025 compared to the prior quarter. Over 3 years (FY 2021 to FY 2025), EPS (Basic) shows an upward trend with a 19.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionEarnings Per Share
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
An increase indicates improved profitability or a reduction in share count, while a decrease suggests declining earnings or equity dilution.
Detailed definition
Basic earnings per share represents the portion of a company's profit allocated to each outstanding share of common stoc...
Peer comparison
Investors compare this across large-cap technology peers to assess the efficiency of earnings generation relative to the equity base.
Metric ID:
is_eps_basicHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.26 | $3.30 | $3.01 | $2.99 | $3.17 | $3.63 | $3.18 | $2.72 | $3.55 | $4.01 | $3.77 | $4.26 | -$13.92 | $4.05 | $2.52 | $4.02 | $4.24 | $4.68 |
| QoQ Change | — | >999% | -8.8% | -0.7% | +6.0% | +14.5% | -12.4% | -14.5% | +30.5% | +13.0% | -6.0% | +13.0% | -426.8% | +129.1% | -37.8% | +59.5% | +5.5% | +10.4% |
| YoY Change | — | — | — | — | >999% | +10.0% | +5.6% | -9.0% | +12.0% | +10.5% | +18.6% | +56.6% | -492.1% | +1.0% | -40.8% | +128.9% | +4.7% | — |
Range-$13.92 – $4.68
CAGR+97.4%
Avg YoY Growth+63.5%
Median YoY Growth+10.0%
Current Streak3 quarters growth
EPS (Basic) at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's eps (basic)?
- Vertex Pharmaceuticals (VRTX) reported eps (basic) of $4.68 in Q4 2025.
- What is the long-term trend for Vertex Pharmaceuticals's eps (basic)?
- Over 3 years (2021 to 2025), Vertex Pharmaceuticals's eps (basic) has grown at a 19.4% compound annual growth rate (CAGR), from $9.09 to $15.46.
- What does eps (basic) mean?
- The amount of profit a company makes for every single share of its common stock currently held by investors.